PLATINUM INVESTMENT MANAGEMENT LTD - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 61 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
PLATINUM INVESTMENT MANAGEMENT LTD ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$951,612
-25.0%
975,012
-20.1%
0.03%
-31.2%
Q4 2022$1,269,630
-9.6%
1,220,7980.0%0.05%
-18.6%
Q3 2022$1,404,000
-31.7%
1,220,798
+11.1%
0.06%
-24.4%
Q2 2022$2,055,000
-34.1%
1,098,888
+6.9%
0.08%
-18.8%
Q1 2022$3,116,000
-19.8%
1,028,3220.0%0.10%
-11.1%
Q4 2021$3,887,000
-26.9%
1,028,3220.0%0.11%
-28.0%
Q3 2021$5,316,000
+19.2%
1,028,322
-11.7%
0.15%
+45.6%
Q2 2021$4,461,000
+241.1%
1,164,746
+128.9%
0.10%
+255.2%
Q1 2021$1,308,000
+2.8%
508,7680.0%0.03%0.0%
Q4 2020$1,272,000
+20.8%
508,7680.0%0.03%
+11.5%
Q3 2020$1,053,000
-33.2%
508,7680.0%0.03%
-27.8%
Q2 2020$1,577,000
+127.6%
508,768
+67.4%
0.04%
+111.8%
Q1 2020$693,000
-37.0%
303,8660.0%0.02%
-22.7%
Q4 2019$1,100,000
+6.2%
303,8660.0%0.02%
-4.3%
Q3 2019$1,036,000
-44.7%
303,866
-23.7%
0.02%
-47.7%
Q2 2019$1,872,000
+12.9%
398,228
-19.5%
0.04%
+12.8%
Q1 2019$1,658,000
+26.0%
494,8290.0%0.04%
-11.4%
Q4 2018$1,316,000
+22.3%
494,829
+157.6%
0.04%
+41.9%
Q3 2018$1,076,000
+70.8%
192,100
+54.7%
0.03%
+106.7%
Q2 2018$630,000
-25.6%
124,2000.0%0.02%
-37.5%
Q1 2018$847,000124,2000.02%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,136,319$3,443,0003.20%
Aquilo Capital Management, LLC 3,708,882$11,238,0001.65%
Soleus Capital Management, L.P. 4,134,868$12,529,0001.62%
GREAT POINT PARTNERS LLC 2,199,076$6,663,0001.61%
BVF INC/IL 5,328,239$16,145,0000.65%
Cutter & CO Brokerage, Inc. 406,229$1,231,0000.37%
WEALTH EFFECTS LLC 80,400$244,0000.11%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$3,116,0000.10%
Rhenman & Partners Asset Management AB 300,000$909,0000.09%
Woodline Partners LP 1,587,475$4,810,0000.08%
View complete list of PIERIS PHARMACEUTICALS INC shareholders